Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Tightens Criteria For Allowing COVID-19 Vaccine Exports

Vaccines Industry Reiterates Warning On Impact Of Restrictions

Executive Summary

As the coronavirus crisis continues to worsen across Europe, the EU authorities have come up with a new way of determining whether exports of coronavirus vaccines should be allowed.

You may also be interested in...



Biden’s Moves On AstraZeneca Stockpile Underscore Power Of Vaccine Diplomacy

America still has a long way to go to meaningfully contribute to ending the global pandemic, but loaning AstraZeneca’s vaccine to Canada and Mexico helps counter the narrative that only China and Russia are helping the rest of the world.

Novavax Plays Down EU COVID Vaccine Contract Delay

Investors are anxious about the delay to Novavax’s deal with the EU, and want to know how and when it might file the vaccine with regulators.

EU Reveals Plans For Boosting COVID-19 Vaccine Supplies

Members of the European Parliament heard from top EU officials on initiatives being undertaken to strengthen the provision of coronavirus vaccines as member states try to deal with a surge in COVID-19 cases.

Related Content

Topics

UsernamePublicRestriction

Register

PS144051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel